Nonsense-mediated mRNA decay: inter-individual variability and human disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neubiorev.2013.10.016PMID 24239855PMCID PMC4021004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases

  2014cited by this paper
• UPF3B gene and nonsense-mediated mRNA decay in autism spectrum disorders

  2014cited by this paper
• Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders.

  2013influential reference
• MicroRNA 125 represses nonsense-mediated mRNA decay by regulating SMG1 expression.

  2013influential reference
• Comparison of EJC-enhanced and EJC-independent NMD in human cells reveals two partially redundant degradation pathways

  2013cited by this paper
• An EJC factor RBM8a regulates anxiety behaviors.

  2013cited by this paper
• A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays

  2013cited by this paper
• Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells.

  2013cited by this paper
• Regulation of nonsense-mediated mRNA decay: implications for physiology and disease.

  2013influential reference
• Comprehensive Clinical and Molecular Analysis of 12 Families with Type 1 Recessive Cutis Laxa

  2013cited by this paper
• Exome sequencing identifies UPF3B as the causative gene for a Chinese non‐syndrome mental retardation pedigree

  2013influential reference
• Two mammalian MAGOH genes contribute to exon junction complex composition and nonsense-mediated decay

  2013cited by this paper
• The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth.

  2013cited by this paper
• Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.

  2013cited by this paper
• Variation and Genetic Control of Protein Abundance in Humans

  2013cited by this paper
• Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability

  2012cited by this paper
• Diversity of animal small RNA pathways and their biological utility

  2012cited by this paper
• A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes

  2012cited by this paper
• Patterns of Cis Regulatory Variation in Diverse Human Populations

  2012influential reference
• Faculty Opinions recommendation of Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome.

  2012influential reference
• Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns

  2012cited by this paper
• Regulation of cytoplasmic mRNA decay

  2012cited by this paper
• Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability

  2012influential reference
• Inheritance of low-frequency regulatory SNPs and a rare null mutation in exon-junction complex subunit RBM8A causes TAR

  2012cited by this paper
• The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.

  2012cited by this paper
• Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity

  2012influential reference
• Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes

  2012influential reference
• Broadening the phenotype associated with mutations in UPF3B: two further cases with renal dysplasia and variable developmental delay.

  2012influential reference
• Gene expression studies in autism: moving from the genome to the transcriptome and beyond.

  2012cited by this paper
• Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression

  2012cited by this paper
• The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus.

  2012cited by this paper
• CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex

  2012cited by this paper
• Regulation of cytoplasmic mRNA decay

  2012cited by this paper
• Regulation of nonsense‐mediated mRNA decay

  2012cited by this paper
• Influence of sex and genetic variability on expression of X-linked genes in human monocytes.

  2011influential reference
• Inhibition of Nonsense-Mediated RNA Decay by the Tumor Microenvironment Promotes Tumorigenesis

  2011influential reference
• Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases

  2011cited by this paper
• Overexpression of the c-myc Oncogene Inhibits Nonsense-mediated RNA Decay in B Lymphocytes*

  2011cited by this paper
• N- and C-terminal Upf1 phosphorylations create binding platforms for SMG-6 and SMG-5:SMG-7 during NMD

  2011cited by this paper
• RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD.

  2011influential reference
• A Copy Number Variation Morbidity Map of Developmental Delay

  2011influential reference
• Autoregulation of the nonsense-mediated mRNA decay pathway in human cells.

  2011cited by this paper
• Out-of-Frame T Cell Receptor Beta Transcripts Are Eliminated by Multiple Pathways In Vivo

  2011cited by this paper
• Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay.

  2011influential reference
• Experimental strategies for microRNA target identification

  2011cited by this paper
• Phenotypic variability and genetic susceptibility to genomic disorders.

  2010cited by this paper
• Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors

  2010influential reference
• Nonsense-Mediated RNA Decay Regulation by Cellular Stress: Implications for Tumorigenesis

  2010cited by this paper
• Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome.

  2010cited by this paper
• The exon junction complex differentially marks spliced junctions

  2010cited by this paper
• miRBase: integrating microRNA annotation and deep-sequencing data

  2010cited by this paper
• A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders

  2010influential reference
• The exon junction complex component Magoh controls brain size by regulating neural stem cell division

  2010cited by this paper
• SMG6 interacts with the exon junction complex via two conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay.

  2010cited by this paper
• Mutations of the UPF3B gene, which encodes a protein widely expressed in neurons, are associated with nonspecific mental retardation with or without autism

  2010influential reference
• Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay

  2010cited by this paper
• A UPF3-mediated regulatory switch that maintains RNA surveillance

  2009influential reference
• Disassembly of exon junction complexes by PYM.

  2009cited by this paper
• SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells

  2009cited by this paper
• SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs.

  2009influential reference
• Gene expression networks: competing mRNA decay pathways in mammalian cells.

  2009cited by this paper
• Long 3′-UTRs target wild-type mRNAs for nonsense-mediated mRNA decay in Saccharomyces cerevisiae

  2009cited by this paper
• The upstream open reading frame of the Arabidopsis AtMHX gene has a strong impact on transcript accumulation through the nonsense-mediated mRNA decay pathway.

  2009cited by this paper
• The Hierarchy of Exon-Junction Complex Assembly by the Spliceosome Explains Key Features of Mammalian Nonsense-Mediated mRNA Decay

  2009cited by this paper
• SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay.

  2009cited by this paper
• Introducing sense into nonsense in treatments of human genetic diseases.

  2008influential reference
• Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

  2008influential reference
• Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues

  2008influential reference
• Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay.

  2008cited by this paper
• SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan.

  2008cited by this paper
• NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements.

  2008cited by this paper
• Hypoxic Inhibition of Nonsense-Mediated RNA Decay Regulates Gene Expression and the Integrated Stress Response

  2008influential reference
• Inter‐kingdom conservation of mechanism of nonsense‐mediated mRNA decay

  2008cited by this paper
• Staufen1 regulates diverse classes of mammalian transcripts

  2007cited by this paper
• Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation

  2007influential reference
• Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements

  2007cited by this paper
• PTC124 targets genetic disorders caused by nonsense mutations

  2007cited by this paper
• The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly

  2007cited by this paper
• Distant N- and C-terminal Domains Are Required for Intrinsic Kinase Activity of SMG-1, a Critical Component of Nonsense-mediated mRNA Decay*

  2007cited by this paper
• Mechanistic insights and identification of two novel factors in the C. elegans NMD pathway.

  2007cited by this paper
• A genome-wide association study of global gene expression

  2007influential reference
• Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.

  2007influential reference
• in Saccharomyces cerevisiae

  2007influential reference
• The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

  2007cited by this paper
• An alternative branch of the nonsense‐mediated decay pathway

  2007influential reference
• A homozygous frameshift mutation in the ESCO2 gene: Evidence of intertissue and interindividual variation in Nmd efficiency

  2006cited by this paper
• The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context.

  2006cited by this paper
• Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease

  2006cited by this paper
• Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay.

  2006cited by this paper
• Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation.

  2006cited by this paper
• hUPF2 Silencing Identifies Physiologic Substrates of Mammalian Nonsense-Mediated mRNA Decay

  2006cited by this paper
• SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway.

  2005cited by this paper
• CBP80 promotes interaction of Upf1 with Upf2 during nonsense-mediated mRNA decay in mammalian cells

  2005cited by this paper
• Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets.

  2005cited by this paper
• Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay.

  2005cited by this paper
• Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements.

  2005cited by this paper
• Upf1p, a highly conserved protein required for nonsense-mediated mRNA decay, interacts with the nuclear pore proteins Nup100p and Nup116p.

  2005cited by this paper
• Association of the Breast Cancer Protein MLN51 with the Exon Junction Complex via Its Speckle Localizer and RNA Binding Module*

  2004cited by this paper
• The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3

  2004cited by this paper
• Nonsense-mediated decay approaches the clinic

  2004cited by this paper

• Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

  2025cites this paper
• Revealing the impact of partial gene duplications in ASH1L: integration of optical genome mapping and RNA sequencing

  2025cites this paper
• Fine-tuning thermogenesis from the post-transcriptional level

  2025cites this paper
• Astrocytic RNA degradation suppresses calcium signaling to support synapse function and restrain anxiety

  2025cites this paper
• Reduced expression of UPF1 promotes tumor progression through stabilizing COX-2 mRNA in nasopharyngeal carcinoma

  2025cites this paper
• Phenotype‐Genotype Correlations in ABCA3 Patients—The RespiRare Cohort

  2025cites this paper
• Genetic disruption of nonsense-mediated mRNA decay in neurodevelopmental disorders.

  2025cites this paper
• Biological roles of nonsense-mediated RNA decay: insights from the nervous system.

  2025cites this paper
• The dynamic interactions between virus infections and nonsense-mediated decay

  2025cites this paper
• Insights From Nonsense‐Mediated mRNA Decay for Prognosis in Homologous Recombination‐Deficient Ovarian Cancer

  2025cites this paper
• Future of Dutch NGS-Based Newborn Screening: Exploring the Technical Possibilities and Assessment of a Variant Classification Strategy

  2024cites this paper
• RNA variant assessment using transactivation and transdifferentiation

  2024cites this paper
• Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema

  2024cites this paper
• Fine-Tuning Amyloid Precursor Protein Expression through Nonsense-Mediated mRNA Decay

  2024cites this paper
• Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay

  2024cites this paper
• Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals

  2024cites this paper
• Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

  2023cites this paper
• Nonsense‐mediated mRNA decay suppresses injury‐induced muscle regeneration via inhibiting MyoD transcriptional activity

  2023cites this paper
• Translation‐coupled mRNA quality control mechanisms

  2023cites this paper
• Small Indels in the Androgen Receptor Gene: Phenotype Implications and Mechanisms of Mutagenesis.

  2023cites this paper
• Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development

  2023cites this paper
• UPF1—From mRNA Degradation to Human Disorders

  2023cites this paper
• Nonsense-mediated RNA decay: an emerging modulator of malignancy

  2022cites this paper
• Case Report And Review Of The Literature: Immune Dysregulation In A Large Familial Cohort Due To A Novel Pathogenic RELA Variant.

  2022cites this paper
• Cfdp1 Is Essential for Cardiac Development and Function

  2022cites this paper
• Nonsense-mediated mRNA decay promote C2C12 cell proliferation by targeting PIK3R5

  2022cites this paper
• Mapping genetic variants for nonsense-mediated mRNA decay regulation across human tissues

  2022cites this paper
• mTOR pathway inhibition stimulates pharmacologically induced nonsense suppression

  2022cites this paper
• Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts

  2022cites this paper
• The impact of TOPBP1 mutations in human cancers on the DNA damage response

  2022cites this paper
• Cross-species Exon Capture and Whole Exome Sequencing: Application, Utility and Challenges for Genomic Resource Development in Non-model Species

  2021cites this paper
• Therapeutic promise of engineered nonsense suppressor tRNAs

  2021cites this paper
• Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum

  2021cites this paper
• Molecular characterisation of rare loss-of-function NPAS3 and NPAS4 variants identified in individuals with neurodevelopmental disorders

  2021cites this paper
• Consequences for Pancreatic β-Cell Identity and Function of Unregulated Transcript Processing

  2021cites this paper
• A novel claudin-10 mutation with a unique mechanism in two unrelated families with HELIX syndrome.

  2021cites this paper
• Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV

  2021cites this paper
• Germline Mutations for Kidney Volume in ADPKD

  2021cites this paper
• Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor

  2021cites this paper
• Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay

  2021cites this paper
• Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy

  2021cites this paper
• Gene therapy for cystic fibrosis: new tools for precision medicine

  2021cites this paper
• UPF3A and UPF3B are redundant and modular activators of nonsense-mediated mRNA decay in human cells

  2021cites this paper
• Deep exploration of a CDKN1C mutation causing a mixture of Beckwith-Wiedemann and IMAGe syndromes revealed a novel transcript associated with developmental delay

  2020cites this paper
• Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations

  2020cites this paper
• Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia

  2020cites this paper
• CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine

  2020cites this paper
• Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance

  2020cites this paper
• Autosomal dominant hereditary spastic paraplegia caused by mutation of UBAP1

  2020cites this paper
• RNA-based therapies in animal models of Leber congenital amaurosis causing blindness

  2020cites this paper
• PAX6 Genotypic and Retinal Phenotypic Characterization in Congenital Aniridia

  2020cites this paper
• Clinical and Genetic Analysis of CHD7 Expands the Genotype and Phenotype of CHARGE Syndrome

  2020cites this paper
• Translational readthrough inducing drugs for the treatment of inherited retinal dystrophies

  2020cites this paper
• UPF1-Mediated RNA Decay—Danse Macabre in a Cloud

  2020cites this paper
• (Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A

  2020cites this paper
• A regulated NMD mouse model supports NMD inhibition as a viable therapeutic option to treat genetic diseases

  2020cites this paper
• The role of the NMD factor UPF3B in olfactory sensory neurons

  2020influential citation
• Complex Multisystem Phenotype With Immunodeficiency Associated With NBAS Mutations: Reports of Three Patients and Review of the Literature

  2020cites this paper
• Genetics in Light of Transcriptional Adaptation.

  2020cites this paper
• UPF3B mutations including a novel synonymous variant associated with absent speech implicate nonsense mediated mRNA decay as a regulator of neurodevelopmental disorder gene networks.

  2020cites this paper
• Missense variant contribution to USP9X-female syndrome

  2020cites this paper
• Evaluation of the Genetic Architecture of Cystic Fibrosis

  2020cites this paper
• Translational read-through inducing drugs for the treatment of inherited 1 retinal dystrophies

  2020cites this paper
• Dynamic Alternative Splicing During Mouse Preimplantation Embryo Development

  2020cites this paper
• UPFront and center in RNA decay: UPF1 in nonsense-mediated mRNA decay and beyond

  2019cites this paper
• Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response.

  2019cites this paper
• How to get away with nonsense: Mechanisms and consequences of escape from nonsense‐mediated RNA decay

  2019cites this paper
• Treating Rett syndrome: from mouse models to human therapies

  2019cites this paper
• Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics

  2019cites this paper
• A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients

  2019cites this paper
• MicroRNA 4651 regulates nonsense-mediated mRNA decay by targeting SMG9 mRNA.

  2019cites this paper
• Decreased mRNA and protein stability of W1282X limits response to modulator therapy.

  2019cites this paper
• Serum starvation enhances nonsense mutation readthrough

  2019cites this paper
• Novel mutations of RPGR in Chinese families with X-linked retinitis pigmentosa

  2019cites this paper
• NMD Takes the Immune Road to NDD.

  2019cites this paper
• Prevalence of ABCA4 Deep-Intronic Variants and Related Phenotype in An Unsolved “One-Hit” Cohort with Stargardt Disease

  2019cites this paper
• Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis

  2018cites this paper
• Genotype–phenotype investigation of 35 patients from 11 unrelated families with camptodactyly–arthropathy–coxa vara–pericarditis (CACP) syndrome

  2018cites this paper
• Residual Cone Structure in Patients With X-Linked Cone Opsin Mutations

  2018cites this paper
• The contribution of alternative splicing to genetic risk for psychiatric disorders

  2018cites this paper
• The exon junction complex: a lifelong guardian of mRNA fate

  2017cites this paper
• p.Val19Glyfs*21 and p.Leu228* variants in the survival of motor neuron 1 trigger nonsense-mediated mRNA decay causing the SMN1 PTC+ transcripts degradation.

  2017cites this paper
• Angiopoietin-1 is required for Schlemm’s canal development in mice and humans

  2017cites this paper
• A Upf3b-mutant mouse model with behavioral and neurogenesis defects

  2017cites this paper
• Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders.

  2017cites this paper
• Stress and the nonsense-mediated RNA decay pathway

  2017cites this paper
• Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay

  2017cites this paper
• Functional analysis by minigene assay of putative splicing variants found in Bardet–Biedl syndrome patients

  2017cites this paper
• Transcript-specific characteristics determine the contribution of endo- and exonucleolytic decay pathways during the degradation of nonsense-mediated decay substrates

  2017cites this paper
• Role of a Dual Splicing and Amino Acid Code in Myopia, Cone Dysfunction and Cone Dystrophy Associated with L/M Opsin Interchange Mutations

  2017cites this paper
• Stress and the nonsense-mediated RNA decay pathway

  2017cites this paper
• A novel de novo COL1A1 mutation in a Thai boy with osteogenesis imperfecta born to consanguineous parents

  2017cites this paper
• Chapter 5 – Transcriptional and Splicing Regulation of Spinal Muscular Atrophy Genes

  2017cites this paper
• Genetic and molecular risk factors within the newly identified primate‐specific exon of the SAP97/DLG1 gene in the 3q29 schizophrenia‐associated locus

  2017cites this paper
• Advanced cell‐based modeling of the royal disease: characterization of the mutated F9 mRNA

  2017cites this paper
• Dual function of UPF3B in early and late translation termination

  2017cites this paper
• Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases

  2016cites this paper
• The Antagonistic Gene Paralogs Upf3a and Upf3b Govern Nonsense-Mediated RNA Decay.

  2016cites this paper
• Nonsense-Mediated RNA Decay Influences Human Embryonic Stem Cell Fate

  2016cites this paper
• Compound heterozygous MYO7A mutations segregating Usher syndrome type 2 in a Han family.

  2016cites this paper